Company Filing History:
Years Active: 2000-2003
Title: The Innovative Contributions of Gorgonio Canaveral
Introduction
Gorgonio Canaveral, an accomplished inventor from Walnut, California, has made significant contributions to the field of immunology through his innovative patents. With a total of three patents to his name, his work primarily focuses on enhancing the safety and efficacy of immunoglobulin solutions for intravenous administration.
Latest Patents
Among his latest patents is the "Method for preparing dual virally inactivated immune globulin for intravenous administration." This groundbreaking process involves producing a gamma globulin solution that is virtually free of contaminating viruses. The method includes fractionating an impure gamma globulin solution and treating the purified product with both solvent-detergent and heat treatments for optimal viral inactivation. Crucially, denatured impurities, residual solvents, and aggregates generated during the heating process are effectively removed from the gamma globulin.
Another notable patent by Canaveral is titled "Method for repairing dual virally inactivated immune globulin for intravenous administration." This invention mirrors his previous efforts to ensure the safety of immunoglobulin solutions, focusing once again on the removal of contaminants through advanced purification techniques.
Career Highlights
Gorgonio Canaveral is currently associated with Alpha Therapeutic Corporation, where he leverages his expertise in immunology to drive forward innovative healthcare solutions. His work not only supports advancements in medical treatments but also emphasizes the importance of safety in therapeutic applications.
Collaborations
Throughout his career, Canaveral has collaborated with talented professionals, including Raja R Mamidi and Andranik Bagdasarian. These collaborations have facilitated the exchange of ideas and research, further enhancing the quality and impact of their collective work in the field of immunology.
Conclusion
With his innovative patents and dedication to improving immunoglobulin safety, Gorgonio Canaveral stands as a notable figure in the realm of medical research. His contributions, particularly in viral inactivation methods, continue to pave the way for advancements in intravenous therapies, highlighting the critical intersection of invention and healthcare.